Expert committee on introduction of incretin-based therapy in Russia: advance and failure
Short resume of expert committees meeting about problems of using of incretin-based therapy in Russian Federation.
Enregistré dans:
Auteur principal: | Editorial team Diabetes Mellitus |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/74a2e7af7ab642bd8b1cfc5da36a49b9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
par: Elena Valer'evna Biryukova
Publié: (2014) -
Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
par: Editorial team Diabetes Mellitus
Publié: (2012) -
Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
par: Lyudmila Viktorovna Nedosugova, et autres
Publié: (2014) -
The new drug saxagliptin is now registrated in Russia
par: Editorial team Diabetes Mellitus
Publié: (2010) -
Vildagliptin: the first innovative DDP-4 inhibitor
par: Edvin Villkhauer
Publié: (2010)